13F

Stock

Fate Therapeutics Inc

FATE · held by 2 managers

Reported value

$253K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$315.1K

Price effect on 2 books still in the name

Largest holder

$251.8K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC118.8K$251.8K−$313.5KCut−$2.03M
Leonteq Securities AG595$1.26K−$1.57KCut−$1.58K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.